TruBridge’s (TBRG) Equal Weight Rating Reiterated at Stephens

Stephens reissued their equal weight rating on shares of TruBridge (NASDAQ:TBRGFree Report) in a report published on Thursday,Benzinga reports. The firm currently has a $28.00 price target on the stock.

Separately, Cantor Fitzgerald increased their price target on TruBridge from $20.00 to $29.00 and gave the stock an “overweight” rating in a research note on Tuesday, March 11th.

Check Out Our Latest Stock Analysis on TBRG

TruBridge Price Performance

TruBridge stock opened at $24.38 on Thursday. The business’s 50 day simple moving average is $27.44 and its 200 day simple moving average is $20.79. TruBridge has a 12 month low of $7.61 and a 12 month high of $32.00. The company has a market cap of $364.46 million, a price-to-earnings ratio of -5.96, a PEG ratio of 5.38 and a beta of 0.64. The company has a current ratio of 1.80, a quick ratio of 1.78 and a debt-to-equity ratio of 1.00.

Insider Buying and Selling

In other TruBridge news, CEO Christopher L. Fowler sold 5,100 shares of the firm’s stock in a transaction on Friday, March 14th. The shares were sold at an average price of $27.02, for a total value of $137,802.00. Following the completion of the transaction, the chief executive officer now directly owns 142,939 shares of the company’s stock, valued at $3,862,211.78. This trade represents a 3.45 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, major shareholder Pinetree Capital Ltd. purchased 34,952 shares of the firm’s stock in a transaction dated Thursday, February 20th. The stock was purchased at an average cost of $27.99 per share, for a total transaction of $978,306.48. Following the acquisition, the insider now owns 768,250 shares of the company’s stock, valued at approximately $21,503,317.50. This trade represents a 4.77 % increase in their position. The disclosure for this purchase can be found here. In the last quarter, insiders have purchased 116,728 shares of company stock valued at $3,239,879. Corporate insiders own 10.70% of the company’s stock.

Institutional Trading of TruBridge

Institutional investors and hedge funds have recently modified their holdings of the business. Charles Schwab Investment Management Inc. bought a new position in shares of TruBridge in the third quarter worth approximately $875,000. FMR LLC bought a new stake in TruBridge during the third quarter valued at approximately $85,000. BNP Paribas Financial Markets purchased a new position in TruBridge in the 3rd quarter worth approximately $161,000. State Street Corp bought a new position in shares of TruBridge in the 3rd quarter worth $829,000. Finally, Jane Street Group LLC purchased a new stake in shares of TruBridge during the 3rd quarter valued at $400,000. Hedge funds and other institutional investors own 88.64% of the company’s stock.

About TruBridge

(Get Free Report)

TruBridge, Inc provides healthcare solutions and services for community hospitals, clinics, and other healthcare systems in the United States and internationally. The company operates in three segments: Revenue Cycle Management (RCM), Electronic Health Record (HER), and Patient Engagement. It focuses on providing RCM solutions for care settings, regardless of primary healthcare information solutions provider along with business management, consulting, managed IT services, and analytics and business intelligence.

Recommended Stories

Receive News & Ratings for TruBridge Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TruBridge and related companies with MarketBeat.com's FREE daily email newsletter.